David S. Krause
Amministratore Delegato presso Genomind, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David M. Brand | M | - |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 15 anni |
| Ronald I. Dozoretz | M | - |
Genomind, Inc.
 Genomind, Inc. Medical/Nursing ServicesHealth Services Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA. | 15 anni |
| David Robbins | M | - |
Genomind, Inc.
Genomind, Inc. Medical/Nursing ServicesHealth Services Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA. | - |
| James Tananbaum | M | 60 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | - |
| John H. Chadwick | M | 57 |
Genomind, Inc.
Genomind, Inc. Medical/Nursing ServicesHealth Services Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA. | - |
| Eric Bednarski | M | 52 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | - |
| Richard Kollender | M | 54 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | - |
| Martin Edwards | M | 68 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | - |
| Theresa Sexton | F | - |
Genomind, Inc.
Genomind, Inc. Medical/Nursing ServicesHealth Services Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA. | - |
| Jennifer D. Copeland | F | - |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 20 anni |
| Rob Gibbs | M | - |
Genomind, Inc.
Genomind, Inc. Medical/Nursing ServicesHealth Services Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA. | - |
| Joseph Anton | M | - |
Genomind, Inc.
Genomind, Inc. Medical/Nursing ServicesHealth Services Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA. | - |
| Kip Olmstead | M | - |
Genomind, Inc.
Genomind, Inc. Medical/Nursing ServicesHealth Services Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA. | 6 anni |
| Stephen Saklad | M | - |
Genomind, Inc.
Genomind, Inc. Medical/Nursing ServicesHealth Services Genomind, Inc. provides molecular diagnostics services. Its changes the trial-and-error approach to treatment planning in psychiatry today and helps clinicians find more effective treatments based on the patient’s genetic profile. The company was founded by Jay L. Lombard and Ronald I. Dozoretz in 2009 and is headquartered in King of Prussia, PA. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| James Gilligan | M | 72 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 9 anni |
| David Milligan | M | 83 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 8 anni |
| Cheryl A. Wenzinger | F | 75 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | - |
| Thomas Hess | M | 60 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 2 anni |
| Linda E. Wiesinger | F | 70 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 2 anni |
| James Cavanaugh | M | 87 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | - |
| Alan Dunton | M | 70 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 1 anni |
| Don Soland | M | 65 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | - |
| George R. Maurer | M | 68 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 5 anni |
| Dinesh Patel | M | 67 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 7 anni |
| Nicholas LaBella | M | 68 |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | 3 anni |
| Joaquim Trias | M | 64 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 9 anni |
| Steven Gelone | M | 56 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 27 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- David S. Krause
- Contatti personali
